[L-5-hydroxytryptophan(L-5-HTP) therapy of Parkinson's disease. 2].
D006916:5-Hydroxytryptophan / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D003863:Depression / Q000150:complications / Q000188:drug therapy; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009127:Muscle Rigidity / Q000150:complications / Q000188:drug therapy; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy*; D014202:Tremor / Q000150:complications / Q000188:drug therapy
D004295:Dihydroxyphenylalanine; D006916:5-Hydroxytryptophan
L-5-Hydroxytryptophan(L-5-HTP)-Therapie des Morbus Parkinson. 2.